Dimensional Fund Advisors’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.54M Buy
563,570
+102,661
+22% +$953K ﹤0.01% 2591
2025
Q4
$5.65M Buy
460,909
+63,607
+16% +$1.04M ﹤0.01% 2494
2025
Q3
$8.14M Buy
397,302
+12,555
+3% +$199K ﹤0.01% 2381
2025
Q2
$5.19M Sell
384,747
-47,314
-11% -$518K ﹤0.01% 2505
2025
Q1
$3.74M Sell
432,061
-12,106
-3% -$74K ﹤0.01% 2584
2024
Q4
$2.16M Buy
444,167
+39,740
+10% +$222K ﹤0.01% 2770
2024
Q3
$3.12M Buy
404,427
+80,297
+25% +$714K ﹤0.01% 2668
2024
Q2
$3.24M Buy
324,130
+35,957
+12% +$395K ﹤0.01% 2631
2024
Q1
$3.5M Buy
288,173
+31,742
+12% +$460K ﹤0.01% 2640
2023
Q4
$3.67M Sell
256,431
-7,025
-3% -$67.4K ﹤0.01% 2642
2023
Q3
$2.05M Buy
263,456
+2,532
+1% +$27.6K ﹤0.01% 2776
2023
Q2
$3.73M Buy
260,924
+80,823
+45% +$1.15M ﹤0.01% 2614
2023
Q1
$2.63M Buy
180,101
+93,110
+107% +$1.56M ﹤0.01% 2667
2022
Q4
$1.46K Buy
86,991
+21,500
+33% +$372K ﹤0.01% 2811
2022
Q3
$970K Sell
65,491
-56,306
-46% -$1.11M ﹤0.01% 2886
2022
Q2
$3.34M Sell
121,797
-63,292
-34% -$1.88M ﹤0.01% 2582
2022
Q1
$6.98M Sell
185,089
-37,566
-17% -$1.66M ﹤0.01% 2433
2021
Q4
$13.8M Sell
222,655
-1,512
-0.7% -$115K ﹤0.01% 2180
2021
Q3
$19.2M Buy
224,167
+68,398
+44% +$4.29M 0.01% 2026
2021
Q2
$9.64M Buy
155,769
+51,396
+49% +$2.62M ﹤0.01% 2373
2021
Q1
$5.11M Buy
104,373
+81,959
+366% +$3.95M ﹤0.01% 2574
2020
Q4
$698K Buy
+22,414
New +$549K ﹤0.01% 3046

Other funds holding OPRX

Dimensional Fund Advisors's OPRX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its OptimizeRx (OPRX) stake by 22% in Q1 2026, buying an estimated $953K and bringing the position to 563,570 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

Dimensional Fund Advisors first reported a position in OPRX in Q4 2020 and has held it in 22 quarters since. The position peaked at $19.2M in Q3 2021. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Dimensional Fund Advisors held 563,570 shares of OptimizeRx worth $3.54M as of Q1 2026.
  • Dimensional Fund Advisors bought 102,661 OptimizeRx shares in Q1 2026, an estimated $953K.
  • OptimizeRx made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2591 holding.
  • Dimensional Fund Advisors first reported a position in OptimizeRx in Q4 2020 and has held it in 22 quarters since.
  • Dimensional Fund Advisors's OptimizeRx position peaked at $19.2M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.